INJECTION SITE PLAQUE

This adverse event was reported 210 times

These drugs are most commonly taken by patients reporting INJECTION SITE PLAQUE:

# Drug Count
0 ETANERCEPT 34
1 DUPILUMAB 26
2 ADALIMUMAB 16
3 IXEKIZUMAB 15
4 OMALIZUMAB 12
5 METHOTREXATE SODIUM 11
6 LEVOTHYROXINE SODIUM 9
7 METHOTREXATE 9
8 MONTELUKAST 9
9 CERTOLIZUMAB PEGOL 7
See all common drugs associated with INJECTION SITE PLAQUE

INJECTION SITE PLAQUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OMALIZUMAB-IGEC 1 0.0112
1 SETMELANOTIDE 1 0.0035
2 HYALURONIC ACID 2 0.0017
3 CAPLACIZUMAB 2 0.0011
4 ADALIMUMAB-RYVK 1 0.0009
5 RILPIVIRINE 5 0.0007
6 CYPROHEPTADINE HYDROCHLORIDE 3 0.0007
7 ANIDULAFUNGIN 1 0.0006
8 CABOTEGRAVIR 4 0.0005
9 UREA 1 0.0005
See all drugs enriched for association with INJECTION SITE PLAQUE